Therapeutically active compounds and their methods of use

US11021515B2 · kind B2 · utility

Assignee

• Agios Pharmaceuticals, Inc. · US

Inventors

• Rene Lemieux · Boston, US
• Janeta Popovici-Muller · Windham, US
• Jeremy Travins · Southborough, US
• Zhenwei Cai · Skillman, US
• Dawei Cui · Shanghai, CN
• Ding Zhou · Shanghai, CN

Key dates

• Filing date: May 11, 2020
• Grant date: Jun 1, 2021
• Expiry date: May 11, 2040

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.